IRCT20150704023055N2
Completed
Phase 2
To evaluate the effectiveness of hemoperfusion in patients with severe coronavirus disease 2019 (COVID-19)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Babol University of Medical Sciences
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with diagnosis of COVID\-19 based on the clinical manifestations, lung CT\-scan, testing of pharyngeal sample using real\-time polymerase chain reaction and the physician´s diagnosis
- •Patients who have partial pressure of oxygen in alveoli (PaO2\) less than 60, even after different methods of oxygen\-therapy
- •Patients who have partial pressure of oxygen in alveoli to the fraction of inspired oxygen (PaO2/FiO2\) less than 200
- •Patients who have partial pressure of carbon dioxide in alveoli (PaCo2\) more than 50; PH less than 7\.35; peripheral capillary oxygen saturation (SpO2\) less than 88%; and no improvement has been achieved despite 48 hours of non\-invasive respiratory therapy
Exclusion Criteria
- •Plasma platelet count less than 30000 per microliter
- •Multiple organ dysfunction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Hemoperfusion in Covid 19IRCT20210718051922N1Shahre-kord University of Medical Sciences60
Recruiting
N/A
Hemoperfusion effect in treatment of patients with COVID-19IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
Completed
N/A
Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japasevere influenza pneumoniaJPRN-UMIN000003669Disease Control and Prevention Center10
Recruiting
Phase 2
The role of hemoperfusion in COVID-19COVID-19.COVID-19U07.1IRCT20200608047686N2Shahid Beheshti University of Medical Sciences40
Recruiting
N/A
Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational StudySevere COVID-19-associated pneumonia with or without hemoperfusion therapyHemoperfusion, adsorption therapy, COVID-19, Pneumonia, Acute respiratory distress syndrome, Critical care, SARS-CoV2, cytokine storm, blood purificationTCTR20210627002Faculty of Medicine, Chiang Mai University15